Jianming Mao

795 total citations
30 papers, 668 citations indexed

About

Jianming Mao is a scholar working on Biomedical Engineering, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Jianming Mao has authored 30 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biomedical Engineering, 9 papers in Materials Chemistry and 5 papers in Molecular Biology. Recurrent topics in Jianming Mao's work include Nanoplatforms for cancer theranostics (13 papers), Metal-Organic Frameworks: Synthesis and Applications (4 papers) and Photodynamic Therapy Research Studies (4 papers). Jianming Mao is often cited by papers focused on Nanoplatforms for cancer theranostics (13 papers), Metal-Organic Frameworks: Synthesis and Applications (4 papers) and Photodynamic Therapy Research Studies (4 papers). Jianming Mao collaborates with scholars based in China, United States and Hong Kong. Jianming Mao's co-authors include Wenbin Lin, Taokun Luo, Guping Tang, Ziwan Xu, Hongzhen Bai, Paul K. Chu, Jiawei Hu, Guojun Huang, Qi Chen and Jianwei Wang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Jianming Mao

29 papers receiving 661 citations

Peers

Jianming Mao
Ze‐Nan Zhuang China
Xiao‐Kang Jin China
Qinghao Zhou China
Jenny W. H. Lou Canada
Xinying Yu China
Yanfeng Gao China
Jungryun Kim South Korea
Xiaowei Luan China
Zhaoming Guo China
Ze‐Nan Zhuang China
Jianming Mao
Citations per year, relative to Jianming Mao Jianming Mao (= 1×) peers Ze‐Nan Zhuang

Countries citing papers authored by Jianming Mao

Since Specialization
Citations

This map shows the geographic impact of Jianming Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianming Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianming Mao more than expected).

Fields of papers citing papers by Jianming Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianming Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianming Mao. The network helps show where Jianming Mao may publish in the future.

Co-authorship network of co-authors of Jianming Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Jianming Mao. A scholar is included among the top collaborators of Jianming Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianming Mao. Jianming Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ya, Jianming Mao, Wenxin Wang, et al.. (2025). Discovery of the first-in-class FABP/PPAR multiple modulator for the treatment of metabolic dysfunction-associated steatohepatitis. European Journal of Medicinal Chemistry. 291. 117635–117635. 2 indexed citations
2.
3.
Mao, Jianming, Andrea Darù, Alexander S. Filatov, et al.. (2025). Structure and Synthesizability of Iron–Sulfur Metal–Organic Frameworks. Journal of the American Chemical Society. 147(21). 17651–17667. 1 indexed citations
4.
Mao, Jianming, et al.. (2025). Discovery of Highly Potent, Selective, and Liver-Targeting HSD17B13 Inhibitor with Robust In Vivo Anti-MASH Activity. Journal of Medicinal Chemistry. 68(11). 11127–11148. 1 indexed citations
5.
6.
Chen, Ya, Mingyang Yu, Jianming Mao, et al.. (2024). Design, synthesis, and biological evaluation of first-in-class FABP1 inhibitors for the treatment of NASH. European Journal of Medicinal Chemistry. 270. 116358–116358. 5 indexed citations
7.
8.
Wang, Wenxin, Ya Chen, Wanqiu Huang, et al.. (2023). Design, synthesis, and biological evaluation studies of novel carboxylesterase 2 inhibitors for the treatment of irinotecan-induced delayed diarrhea. Bioorganic Chemistry. 138. 106625–106625. 5 indexed citations
9.
Li, Youyou, Wenbo Han, Deyan Gong, et al.. (2023). A self-assembled nanophotosensitizer targets lysosomes and induces lysosomal membrane permeabilization to enhance photodynamic therapy. Chemical Science. 14(19). 5106–5115. 17 indexed citations
10.
Jiang, Xiaomin, Jianming Mao, Wenbo Han, et al.. (2023). Pharmacological ascorbate potentiates combination nanomedicines and reduces cancer cell stemness to prevent post-surgery recurrence and systemic metastasis. Biomaterials. 295. 122037–122037. 9 indexed citations
11.
Zhang, Yuhan, et al.. (2023). Facile preparation of gold nanoparticles anchored on layered yttrium hydroxide by electrochemical methods for enhanced sensing of hydroquinone and catechol. Materials Chemistry and Physics. 311. 128526–128526. 11 indexed citations
12.
Luo, Taokun, et al.. (2023). Metal‐Organic Layer Delivers 5‐Aminolevulinic Acid and Porphyrin for Dual‐Organelle‐Targeted Photodynamic Therapy. Angewandte Chemie International Edition. 62(22). e202301910–e202301910. 23 indexed citations
13.
Liu, Jing, Xiaomin Jiang, Xuanyu Feng, et al.. (2023). A Three‐in‐One Nanoscale Coordination Polymer for Potent Chemo‐Immunotherapy. Small Methods. 7(5). e2201437–e2201437. 11 indexed citations
14.
15.
Jiang, Xiaomin, Wenbo Han, Jianqiao Liu, et al.. (2022). Tumor‐Activatable Nanoparticles Target Low‐Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy. Advanced Science. 9(24). e2201614–e2201614. 33 indexed citations
16.
Huang, Guojun, Qi Chen, Jiawei Hu, et al.. (2021). Chitosan-derived nanoparticles impede signal transduction in T790M lung cancer therapy. Biomaterials Science. 9(22). 7412–7419. 7 indexed citations
17.
Phan, Chi Uyen, et al.. (2021). Impact of Crystal Habit on the Dissolution Rate and In Vivo Pharmacokinetics of Sorafenib Tosylate. Molecules. 26(11). 3469–3469. 19 indexed citations
18.
Guo, Nining, Kaiyuan Ni, Taokun Luo, et al.. (2021). Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy–Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression. ACS Nano. 15(11). 17515–17527. 37 indexed citations
19.
Mao, Jianming, Jianwei Wang, Guping Tang, Paul K. Chu, & Hongzhen Bai. (2020). A zipped-up tunable metal coordinated cationic polymer for nanomedicine. Journal of Materials Chemistry B. 8(7). 1350–1358. 8 indexed citations
20.
Chen, Qi, Guojun Huang, Wangteng Wu, et al.. (2020). A Hybrid Eukaryotic–Prokaryotic Nanoplatform with Photothermal Modality for Enhanced Antitumor Vaccination. Advanced Materials. 32(16). e1908185–e1908185. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ze‐Nan Zhuang Breakdown of academic impact, for papers by Xiao‐Kang Jin Breakdown of academic impact, for papers by Qinghao Zhou Breakdown of academic impact, for papers by Jenny W. H. Lou Breakdown of academic impact, for papers by Xinying Yu Breakdown of academic impact, for papers by Yanfeng Gao Breakdown of academic impact, for papers by Jungryun Kim Breakdown of academic impact, for papers by Xiaowei Luan Breakdown of academic impact, for papers by Zhaoming Guo
Rankless by CCL
2026